GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Fonar Corp (NAS:FONR) » Definitions » Cyclically Adjusted Price-to-FCF

Fonar (FONR) Cyclically Adjusted Price-to-FCF : 6.15 (As of Jun. 08, 2024)


View and export this data going back to 1981. Start your Free Trial

What is Fonar Cyclically Adjusted Price-to-FCF?

As of today (2024-06-08), Fonar's current share price is $15.67. Fonar's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was $2.55. Fonar's Cyclically Adjusted Price-to-FCF for today is 6.15.

The historical rank and industry rank for Fonar's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

FONR' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 5.16   Med: 12.28   Max: 255.8
Current: 6.16

During the past years, Fonar's highest Cyclically Adjusted Price-to-FCF was 255.80. The lowest was 5.16. And the median was 12.28.

FONR's Cyclically Adjusted Price-to-FCF is ranked better than
90.48% of 63 companies
in the Medical Diagnostics & Research industry
Industry Median: 35.48 vs FONR: 6.16

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Fonar's adjusted free cash flow per share data for the three months ended in Mar. 2024 was $0.405. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is $2.55 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Fonar Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Fonar's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fonar Cyclically Adjusted Price-to-FCF Chart

Fonar Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.74 11.02 7.99 6.23 6.76

Fonar Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.58 6.76 6.12 7.80 8.39

Competitive Comparison of Fonar's Cyclically Adjusted Price-to-FCF

For the Diagnostics & Research subindustry, Fonar's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fonar's Cyclically Adjusted Price-to-FCF Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Fonar's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Fonar's Cyclically Adjusted Price-to-FCF falls into.



Fonar Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Fonar's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=15.67/2.55
=6.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fonar's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Fonar's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.405/131.7762*131.7762
=0.405

Current CPI (Mar. 2024) = 131.7762.

Fonar Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 0.675 100.560 0.885
201409 0.447 100.428 0.587
201412 0.471 99.070 0.626
201503 0.400 99.621 0.529
201506 0.744 100.684 0.974
201509 0.539 100.392 0.708
201512 0.644 99.792 0.850
201603 0.355 100.470 0.466
201606 0.966 101.688 1.252
201609 0.426 101.861 0.551
201612 0.365 101.863 0.472
201703 0.386 102.862 0.495
201706 1.052 103.349 1.341
201709 0.465 104.136 0.588
201712 0.611 104.011 0.774
201803 0.462 105.290 0.578
201806 0.923 106.317 1.144
201809 0.510 106.507 0.631
201812 0.626 105.998 0.778
201903 0.404 107.251 0.496
201906 0.924 108.070 1.127
201909 0.273 108.329 0.332
201912 0.559 108.420 0.679
202003 0.271 108.902 0.328
202006 0.838 108.767 1.015
202009 0.509 109.815 0.611
202012 0.602 109.897 0.722
202103 0.247 111.754 0.291
202106 0.794 114.631 0.913
202109 0.005 115.734 0.006
202112 0.542 117.630 0.607
202203 0.389 121.301 0.423
202206 0.661 125.017 0.697
202209 0.260 125.227 0.274
202212 0.405 125.222 0.426
202303 0.315 127.348 0.326
202306 0.531 128.729 0.544
202309 0.388 129.860 0.394
202312 0.600 129.419 0.611
202403 0.405 131.776 0.405

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Fonar  (NAS:FONR) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Fonar Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Fonar's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Fonar (FONR) Business Description

Traded in Other Exchanges
Address
110 Marcus Drive, Melville, NY, USA, 11747
Fonar Corp is a United States-based company which is engaged in the business of designing, manufacturing, selling and servicing magnetic resonance imaging (MRI) scanners, which utilize MRI technology for the detection and diagnosis of human disease, abnormalities, other medical conditions, and injuries. The company operates through two segments namely Manufacturing and servicing of medical equipment; and the Management of diagnostic imaging centers, which generates a vast majority of the revenue. The company's areas of operations are principally in the United States. It also exports to the United Arab Emirates, England, and Germany.
Executives
Timothy Raymond Damadian director, officer: CEO, President & Treasurer 110 MARCUS DR., MELVILLE NY 11747
Luciano B Bonanni officer: Exec VP, COO & PFO 110 MARCUS DR., MELVILLE NY 11747
Raymond V Damadian director, officer: president 31 FAIRBANKS BLVD, WOODBURY NY 11797
Robert J Janoff director 32 OSAGE DRIVE, HUNTINGTON STATION NY 11746
Data Charles O director 347 LINCOLN AVENUE, BEAVER PA 15009
Claudette Chan director 145 WEST 86TH STREET, APT. 15B, NEW YORK NY 10024
David B Terry officer: Secretary BOX 1439, EAST QUOGUE NY 11942
Robert Djerejian director 303 EAST 57TH STREET, APT 16LA, NEW YORK NY 10022